NKTR 8-K 2026-08-13

NEKTAR THERAPEUTICS (NKTR) 8-K dated 2026-08-13 — accession 0001213900-26-089137. This URL is the filing, not the NKTR hub.

NEKTAR THERAPEUTICS (NKTR) is a biotechnology company listed on US.

NEKTAR THERAPEUTICS filed a 8-K on 2026-08-13. Accession 0001213900-26-089137.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.

Not investment advice. The NKTR SEC hub lists recent forms. The stock page is the research view.